Division of Colorectal Surgery, Department of Surgery, University of Michigan, Ann Arbor.
JAMA. 2014 Jan 15;311(3):287-97. doi: 10.1001/jama.2013.282025.
Diverticulitis is a common disease. Recent changes in understanding its natural history have substantially modified treatment paradigms.
To review the etiology and natural history of diverticulitis and recent changes in treatment guidelines.
We searched the MEDLINE and Cochrane databases for English-language articles pertaining to diagnosis and management of diverticulitis published between January 1, 2000, and March 31, 2013. Search terms applied to 4 thematic topics: pathophysiology, natural history, medical management, and indications for surgery. We excluded small case series and articles based on data accrued prior to 2000. We hand searched the bibliographies of included studies, yielding a total of 186 articles for full review. We graded the level of evidence and classified recommendations by size of treatment effect, according to the guidelines from the American Heart Association Task Force on Practice Guidelines.
Eighty articles met criteria for analysis. The pathophysiology of diverticulitis is associated with altered gut motility, increased luminal pressure, and a disordered colonic microenvironment. Several studies examined histologic commonalities with inflammatory bowel disease and irritable bowel syndrome but were focused on associative rather than causal pathways. The natural history of uncomplicated diverticulitis is often benign. For example, in a cohort study of 2366 of 3165 patients hospitalized for acute diverticulitis and followed up for 8.9 years, only 13.3% of patients had a recurrence and 3.9%, a second recurrence. In contrast to what was previously thought, the risk of septic peritonitis is reduced and not increased with each recurrence. Patient-reported outcomes studies show 20% to 35% of patients managed nonoperatively progress to chronic abdominal pain compared with 5% to 25% of patients treated operatively. Randomized trials and cohort studies have shown that antibiotics and fiber were not as beneficial as previously thought and that mesalamine might be useful. Surgical therapy for chronic disease is not always warranted.
Recent studies demonstrate a lesser role for aggressive antibiotic or surgical intervention for chronic or recurrent diverticulitis than was previously thought necessary.
憩室炎是一种常见疾病。最近对其自然史的认识变化极大地改变了治疗模式。
回顾憩室炎的病因和自然史以及治疗指南的最新变化。
我们在 MEDLINE 和 Cochrane 数据库中检索了 2000 年 1 月 1 日至 2013 年 3 月 31 日期间发表的有关憩室炎诊断和治疗的英文文章。检索词适用于 4 个主题:病理生理学、自然史、医学治疗和手术适应证。我们排除了小型病例系列和数据来源于 2000 年之前的文章。我们对纳入研究的参考文献进行了手工检索,共检索到 186 篇全文进行评估。我们根据美国心脏协会实践指南工作组的指南,对证据水平进行分级,并根据治疗效果的大小对推荐意见进行分类。
80 篇文章符合分析标准。憩室炎的病理生理学与肠道运动改变、腔内压力增加和结肠微环境紊乱有关。一些研究检查了与炎症性肠病和肠易激综合征的组织学共同点,但重点是关联而不是因果途径。单纯性憩室炎的自然史通常是良性的。例如,在一项对 3165 例因急性憩室炎住院并随访 8.9 年的患者中的 2366 例患者的队列研究中,只有 13.3%的患者复发,3.9%的患者第二次复发。与之前的观点相反,每次复发时发生感染性腹膜炎的风险并没有增加。患者报告的结局研究显示,20%至 35%接受非手术治疗的患者进展为慢性腹痛,而接受手术治疗的患者为 5%至 25%。随机试验和队列研究表明,抗生素和纤维的疗效不如以前认为的那样有效,美沙拉嗪可能有用。慢性疾病的手术治疗并非总是必要的。
最近的研究表明,与以前认为的相比,对于慢性或复发性憩室炎,积极的抗生素或手术干预的作用较小。